Gonadotropin [EPC]

2190 reported adverse events

Drugs of this class: ACETALDEHYDE, DOPAMINE HYDROCHLORIDE, DHEA (DEHYDROEPIANDROSTERONE), 7-OXO- DEHYDROEPIANDROSTERONE 3-ACETATE, FOLLICULINUM, OOPHORINUM (SUIS), CHOLESTERINUM, PROGESTERONE, TESTOSTERONE, CORTISONE ACETICUM, ALDOSTERONE, ANDROSTERONE, FOLLICLE STIMULATING HORMONE FOLLITROPIN ACETALDEHYDE, DOPAMINE HYDROCHLORIDE, DHEA (DEHYDROEPIANDROSTERONE), 7-OXO-DEHYDROEPIANDROSTERONE-3B-ACETATE, FOLLICULINUM, OOPHORINUM (SUIS), CHOLESTERINUM, PROGESTERONE, TESTOSTERONE, CORTISONE ACETICUM, ALDOSTERONE, ANDROSTERONE, FOLLICLE STIMULATING HORMONE CHORIOGONADOTROPIN ALFA

These side effects are most commonly reported by patients taking drugs of the Gonadotropin [EPC] class:

# Side effect Count
0 OVARIAN HYPERSTIMULATION SYNDROME 483
1 NO ADVERSE EVENT 176
2 ABDOMINAL DISTENSION 144
3 HEADACHE 140
4 NAUSEA 115
5 POOR QUALITY DEVICE USED 91
6 ASCITES 85
7 FATIGUE 81
8 ABDOMINAL PAIN 79
9 PRODUCT PACKAGING QUANTITY ISSUE 76
See all common reactions for Gonadotropin [EPC]

Drugs of the Gonadotropin [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHOLANGIOSARCOMA 3 0.3750
1 OVARIAN HYPERSTIMULATION SYNDROME 483 0.2070
2 OVULATION INDUCTION 2 0.1538
3 OPTIC NERVE SHEATH MENINGIOMA 3 0.1364
4 OVARIAN HAEMORRHAGE 22 0.0928
5 DECREASED EMBRYO VIABILITY 2 0.0833
6 MULTIPLE PREGNANCY 10 0.0559
7 OVARIAN ENLARGEMENT 21 0.0547
8 PROGESTERONE INCREASED 5 0.0450
9 VANISHING TWIN SYNDROME 4 0.0449
See all enriched reactions for Gonadotropin [EPC]